UNITE® Technology: Translating lysosomal targeting vaccines for allergy therapy.
Allergic diseases affect more than 30-40% of the global population and continue to rise in prevalence, creating a substantial clinical and economic burden. Current treatments-including antihistamines, corticosteroids, biologics, and allergen immunotherapy-primarily provide symptomatic relief or require prolonged treatm...